Fortis Healthcare · NSE: FORTIS · BSE: 532843

Q4 FY21 results · Jan–Mar 2021

Fortis Healthcare reported revenue from operations of ₹1,252.44 crore (up 12.5% from Q4 FY20) and net profit of ₹62.36 crore for Q4 FY21 (Jan–Mar 2021), on a consolidated basis.

Consolidated · ₹ crore
Item	Q4 FY21	Q4 FY20	YoY	Q3 FY21	QoQ
Revenue from operations	1,252.44	1,112.92	+12.5%	1,177.03	+6.4%
Other income	6.34	18.41	−65.6%	10.17	−37.7%
Total income	1,258.78	1,131.33	+11.3%	1,187.20	+6.0%
Profit before share of associates & JVs and tax	91.64	7.16	13x	85.41	+7.3%
Share of profit/(loss) of associates & JVs	18.73	2.02		17.72
Net profit for the period	62.36	(41.24)	Turned profit	53.88	+15.7%
Attributable to shareholders of the company	43.17	(44.51)	Turned profit	29.90	+44.4%
EPS, basic (₹)	0.57	(0.59)	Turned profit	0.40	+42.5%
Net margin (%)	5.0	-3.7		4.6

This company reports a share of profit/(loss) from associates and joint ventures. BSE’s filing format records that share after tax, so it is shown on its own line. The company’s own statement may add it before its “profit before tax” line.

Standalone · ₹ crore
Item	Q4 FY21	Q4 FY20	YoY	Q3 FY21	QoQ
Revenue from operations	194.82	167.79	+16.1%	184.36	+5.7%
Other income	27.38	56.32	−51.4%	56.55	−51.6%
Total income	222.20	224.11	−0.9%	240.91	−7.8%
Profit before tax	(45.09)	4.40	Turned loss	32.41	Turned loss
Net profit for the period	(41.10)	8.12	Turned loss	21.25	Turned loss
EPS, basic (₹)	(0.54)	0.11	Turned loss	0.28	Turned loss
Net margin (%)	-21.1	4.8		11.5

Consolidated

Filed with BSE: 29 May 2021, 19:32 IST
Board meeting: 29 May 2021
Period: 01 Jan 2021 to 31 Mar 2021
Review status: Audited
Source: XBRL filing on BSE

Standalone

Filed with BSE: 29 May 2021, 19:32 IST
Board meeting: 29 May 2021
Period: 01 Jan 2021 to 31 Mar 2021
Review status: Audited
Source: XBRL filing on BSE